Helaina

Helaina is a biotechnology company that uses precision fermentation to create human-equivalent bioactive proteins for nutritional applications. Their flagship product, effera™ Human Lactoferrin, supports women's health, active nutrition, and healthy aging. The company partners with consumer brands and distributors to bring these innovative ingredients to market.

Funding Round: Series B

Funding Amount: $45M

Date: 25-Sep-2024

Investors: Avidity Partners, Spark Capital, Ingeborg Investments, Tom Williams of Heron Rock, Barrel Ventures, Siam Capital, Relish Works, CF Private Equity, Primary Venture Partners

Markets: Biotechnology, Nutrition, Food Science, Health Care

HQ: New York, New York, United States

Founded: 2019

Website: https://www.myhelaina.com/

LinkedIn: https://www.linkedin.com/company/helaina/

Twitter:

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/helaina

Pitchbook: https://pitchbook.com/profiles/company/279783-82